Cargando…

FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells

INTRODUCTION: Multiple myeloma (MM) development involves a series of genetic abnormalities and changes in the bone marrow (BM) microenvironment, favoring the growth of the tumor and failure of local immune control. T regulatory (Treg) cells play an important role in dampening anti-tumor immune respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braga, Walter Moises Tobias, da Silva, Bruna Raphaeli, de Carvalho, Ana Carolina, Maekawa, Yumi H., Bortoluzzo, Adriana Bruscato, Rizzatti, Edgar Gil, Atanackovic, Djordje, Colleoni, Gisele Wally Braga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209089/ https://www.ncbi.nlm.nih.gov/pubmed/25099367 http://dx.doi.org/10.1007/s00262-014-1589-9

Ejemplares similares

The Role of Regulatory T Cells and TH17 Cells in Multiple Myeloma
por: Braga, Walter M. T., et al.
Publicado: (2012)

Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma
por: Fernando, Rodrigo Carlini, et al.
Publicado: (2021)

Multiple myeloma cell lines and primary tumors proteoma: protein biosynthesis and immune system as potential therapeutic targets
por: Fernando, Rodrigo Carlini, et al.
Publicado: (2015)

Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism
por: Fernando, Rodrigo Carlini, et al.
Publicado: (2019)

CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria
por: Barnes, M J, et al.
Publicado: (2013)

Biochemical phenotyping of multiple myeloma patients at diagnosis reveals a disorder of mitochondrial complexes I and II and a Hartnup-like disturbance as underlying conditions, also influencing different stages of the disease
por: da Silva, Ismael Dale Cotrim Guerreiro, et al.
Publicado: (2020)

Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma
por: Eugênio, Angela Isabel Pereira, et al.
Publicado: (2017)

Expression of CTLA-4 and Foxp3 in peripheral blood T cells of patients with squamous cell laryngeal carcinoma
por: Starska, Katarzyna, et al.
Publicado: (2013)

Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma
por: Koike, Kazushige, et al.
Publicado: (2020)

FOXP3 and CTLA-4 genetic variants' influence on the susceptibility and clinical course of basal cell carcinoma
por: Sławińska, Martyna, et al.
Publicado: (2020)

CTLA4(+)CD4(+)CXCR5(−)FOXP3(+) T cells associate with unfavorable outcome in patients with chronic HBV infection
por: Wen, Chunhua, et al.
Publicado: (2023)

Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma
por: Gonzalez-Montes, Yolanda, et al.
Publicado: (2023)

Targeting MAGE-C1/CT7 Expression Increases Cell Sensitivity to the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cell Lines
por: de Carvalho, Fabricio, et al.
Publicado: (2011)

Higher proportions of circulating FOXP3(+) and CTLA-4(+) regulatory T cells are associated with lower fractions of memory CD4(+) T cells in infants
por: Rabe, Hardis, et al.
Publicado: (2011)

Evaluation of CD4+ CD25+ FoxP3+ Regulatory T cells and FoxP3 and CTLA-4 gene Expression in Patients wwith Newly Diagnosed Tuberculosis in Northeast of Iran
por: Ghazalsofala, Roghayeh, et al.
Publicado: (2015)

May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control?
por: da Silva, Ismael Dale Cotrim Guerreiro, et al.
Publicado: (2021)

CTLA4-Ig Effectively Controls Clinical Deterioration and Immune Condition in a Murine Model of Foxp3 Deficiency
por: Gerbaux, Margaux, et al.
Publicado: (2023)

CTLA-4 Modulates the Differentiation of Inducible Foxp3(+) Treg Cells but IL-10 Mediates Their Function in Experimental Autoimmune Encephalomyelitis
por: Verhagen, Johan, et al.
Publicado: (2014)

Accumulation of CCR4(+) CTLA-4(hi) FOXP3(+)CD25(hi) Regulatory T Cells in Colon Adenocarcinomas Correlate to Reduced Activation of Conventional T Cells
por: Svensson, Helena, et al.
Publicado: (2012)

Modulation of the immune response in HTLV-1-infections by SM29 antigen in vitro is dependent of IL-10, TGF-β and CTLA-4
por: Lima, Luciane Mota, et al.
Publicado: (2014)

Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms
por: Berry, Andrew, et al.
Publicado: (2008)

Variations in Suppressor Molecule CTLA-4 Gene Are Related to Susceptibility to Multiple Myeloma in a Polish Population
por: Karabon, Lidia, et al.
Publicado: (2011)

Plasma cell leukemia with t(11;14)(q13;q32) simulating lymphoplasmacytic lymphoma – a diagnostic challenge solved by flow cytometry
por: Loureiro, Aleyde Diniz, et al.
Publicado: (2017)

CTLA-4: From conflict to clinic
por: Bashyam, Hema
Publicado: (2007)

The role of CTLA-4 in immune regulation
por: Verhagen, Johan, et al.
Publicado: (2008)

Analysis of protein profile expressed on the membrane surface of plasma cells, stromal cells and mononuclear cells from bone marrow microenvironment of multiple myeloma patients by mass spectrometry
por: de Carvalho, Fabricio, et al.
Publicado: (2013)

Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
por: Watanabe, Tomofumi, et al.
Publicado: (2023)

Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry
por: Rojas-Restrepo, Jessica, et al.
Publicado: (2023)

Overexpression of Regulatory T Cell-Related Markers (FOXP3, CTLA-4 and GITR) by Peripheral Blood Mononuclear Cells from Patients with Breast Cancer
por: Khalife, Esmat, et al.
Publicado: (2018)

Immune inhibitory function of bovine CTLA-4 and the effects of its blockade in IFN-γ production
por: Watari, Kei, et al.
Publicado: (2019)

Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4(+)Foxp3(+) Treg Induction
por: Massalska, Magdalena, et al.
Publicado: (2022)

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
por: Peggs, Karl S., et al.
Publicado: (2009)

CTLA-4 Insufficiency due to a Novel CTLA-4 Deletion, Identified through Copy Number Variation Analysis
por: Olfe, Lisa, et al.
Publicado: (2022)

Correction to: Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4‑Dependent Transendocytosis by Flow Cytometry
por: Rojas‑Restrepo, Jessica, et al.
Publicado: (2023)

The synergic effects of CTLA-4/Foxp3-related genotypes and chromosomal aberrations on the risk of recurrent spontaneous abortion among a Chinese Han population
por: Fan, Qin’e, et al.
Publicado: (2018)

CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4
por: Halliday, Neil, et al.
Publicado: (2020)

Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation
por: Templin, Julia, et al.
Publicado: (2017)

CTLA4 polymorphism and primary Sjögren's syndrome
por: Lester, Susan, et al.
Publicado: (2007)

CTLA-4 based therapy (MDX-010)
por: Korman, A
Publicado: (2003)

CTLA-4 and Autoimmunity: New Twists in the Tale
por: Walker, Lucy S.K.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3ngpfna8sbk6aadlngorhj63vb